When a Product Fails, Find a New Direction
Harvard Business Review
FEBRUARY 22, 2013
Having observed management teams for decades as a mutual fund and portfolio manager, I have watched numerous companies vanish after a disastrous launch of a product or service. Cephalon's IPO was in 1991, part of the second wave of biotechnology companies to sell shares to the public. What do you do next?
8 
Let's personalize your content